Top news of the week: 07.04.2020.

#BioTech #COVID19 #drugdiscovery #SensyneHealth #pharma #research #healthcare #InThisTogether #coronavirus #WeWontRest

Healthcare

On Apr 6, 2020
@SensyneHealth shared
#SensyneHealth's @RabiaTKhan commenting on how machine learning can go beyond classical approaches to help identify pateint sub-groups https://t.co/7gI2AyBdhj @GENbio #drugdiscovery #pharma #research #healthcare #biotech https://t.co/H4uDPv0Ixf
Open

Artificial Intelligence Is Helping Biotech Get Real

Artificial Intelligence Is Helping Biotech Get Real

No longer the stuff of fantasy, AI is entering the real world everywhere—biotech included. AI’s biotech applications include drug target identification, drug screening, and the analysis of ...

On Apr 1, 2020
@WendyBlackburn shared
RT @NYTHealth: Covid-19 has ignited a global scientific collaboration unlike any in history. Never before have so many experts in so many countries focused - so openly and urgently - on a single topic. Nearly all other research has ground to a halt. https://t.co/unRvffXjm0
Open

Covid-19 Changed How the World Does Science, Together

Covid-19 Changed How the World Does Science, Together

Never before, scientists say, have so many of the world’s researchers focused so urgently on a single topic. Nearly all other research has ground to a halt.

On Apr 4, 2020
@matthewherper shared
RT @lisamjarvis: The first vaccines entering human studies in #COVID19 are based on gene-based technologies that have yet to be proven. @RLCscienceboss breaks down the science, caveats, and asks what this #coronavirus pressure test could mean for mRNA & DNA vaccines: https://t.co/hsi20tZan0
Open

Will the coronavirus help mRNA and DNA vaccines prove their worth?

Will the coronavirus help mRNA and DNA vaccines prove their worth?

As gene-based vaccines are being designed and tested at unprecedented speeds to fight COVID-19, scientists wonder if this will be the technology’s make-or-break moment.

On Apr 3, 2020
@BiotechSweden shared
Biopharma Update on the Novel Coronavirus: March 31 https://t.co/7WgLlJ9XHc https://t.co/L6OWfUb1KO
Open

Biopharma Update on the Novel Coronavirus: March 31

Biopharma Update on the Novel Coronavirus: March 31

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 31, 2020.

On Apr 3, 2020
@BiotechSweden shared
In Other (Biopharma) News: Non-Coronavirus Stories this Week https://t.co/717LtDarhG https://t.co/vI3lUzDKzO
Open

In Other (Biopharma) News: Non-Coronavirus Stories this Week

In Other (Biopharma) News: Non-Coronavirus Stories this Week

The following is a roundup of some of this week's non-coronavirus biopharma news.

On Apr 1, 2020
@BiotechSweden shared
Cell therapy touted as possible coronavirus treatment by Cleveland biotech company #BioTech via https://t.co/2sI0UxJbpn https://t.co/Et0upIvig3
Open

Cell therapy touted as possible coronavirus treatment by Cleveland biotech company

Cell therapy touted as possible coronavirus treatment by Cleveland biotech company

The coronavirus has killed more than 4,000 people in the United States so far, and the race is on to find a vaccine, along with other treatments, to save the lives of those who are already ...

On Apr 6, 2020
@ABPI_UK shared
How are companies are researching treatments, vaccines and diagnostics for #COVID19? Find out more here: https://t.co/JsEHhmdiiw
Open

What are pharmaceutical companies doing to tackle COVID-19?

What are pharmaceutical companies doing to tackle COVID-19?

There are significant global efforts underway to diagnose, treat and prevent infections from the virus. Pharmaceutical companies are working globally to combat COVID-19.

On Apr 3, 2020
@BiotechSweden shared
The 9 top biotech stocks to buy now to get through the coronavirus crisis, according to JPMorgan #BioTech via https://t.co/2sI0UxJbpn https://t.co/xhCjwIs8dp
Open

The 9 top biotech stocks to buy now to get through the coronavirus crisis, according to JPMorgan

The 9 top biotech stocks to buy now to get through the coronavirus crisis, according to JPMorgan

The biotech industry has outperformed in past downturns. Here are JPMorgan's top choices to invest in now.